Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth

Cancer Research

Volumn 72, Issue 14, 2012, Pages 3512-3521

  Holopainen, Tanja ^a   Loṕez Alpuche, Vanessa ^c   Zheng, Wei ^a   Heljasvaara, Ritva ^c   Jones, Dennis ^d   He, Yun ^d   Tvorogov, Denis ^a   D'Amico, Gabriela ^a   Wiener, Zoltan ^a   Andersson, Leif C ^b   Pihlajaniemi, Taina ^c   Min, Wang ^d   Alitalo, Kari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BMX; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMX GENE; CANCER CELL; COLON TUMOR; CONTROLLED STUDY; DIGESTIVE SYSTEM TUMOR; ENDOTHELIUM CELL; FEMALE; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; KERATINOCYTE; LUNG TUMOR; MALE; MELANOMA B16; MOUSE; NONHUMAN; ONCOGENE; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN CARCINOGENESIS; TUMOR GROWTH;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-TYROSINE KINASES;

EID: 84863955477     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1070     Document Type: Article

References (36)

1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:193-200.
2. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2011;411:355-65.
3. Tamagnone L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994;9:3683-88.
4. Saharinen P, Ekman N, Sarvas K, Parker P, Alitalo K, Silvennoinen O. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood 1997;90:4341-53. (Pubitemid 27508440)
5. EkmanN, Arighi E, Rajantie I, Saharinen P, Ristimäki A, Silvennoinen O, et al. TheBmxtyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 2000;19:4151-58.
6. Rajantie I, Ekman N, Iljin K, Arighi E, Gunji Y, Kaukonen J, et al. Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol Cell Biol 2001;21:4647-55. (Pubitemid 32588247)
7. Paavonen K, Ekman N, Wirzenius M, Rajantie I, Poutanen M, Alitalo K. Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing. Mol Biol Cell 2004;15: 4226-33. (Pubitemid 39122025)
8. Folkman J. Angiogenesis and tumor growth. N Engl J Med 1996; 334:920-21.
9. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-48.
10. He Y, Luo Y, Tang S, Rajantie I, Salven P, Heil M, et al. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest 2006;116:2344-55. (Pubitemid 44330133)
11. Luo Y, Xu Z, Wan T, He Y, Jones D, Zhang H, et al. Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 2010;30:1307-14.
12. Jones D, Xu Z, Zhang H, He Y, Kluger MS, Chen H, et al. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Arterioscler Thromb Vasc Biol 2010;30:2553-61.
13. Gottar-Guillier M, Dodeller F, Huesken D, Iourgenko V, Mickanin C, Labow M, et al. The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. J Immunol 2011;186:6014-23.
14. Dai B, Chen H, Guo S, Yang X, Linn DE, Sun F, et al. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells. Cancer Res 2010;70:5587-96.
15. Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, Yang J, et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011;19:498-511.
16. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-122. (Pubitemid 15064530)
17. Reynolds LE, Hodivala-Dilke KM. Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol Med 2006;120: 503-9.
18. Brideau G, Mäkinen MJ, Elamaa H, Tu H, Nilsson G, Alitalo K, et al. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res 2007;67:11528-35.
19. Korsisaari N, Kasman IM, Forrest WF, Pal N, Bai W, Fuh G, et al. Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice. Proc Natl Acad Sci U S A 2007;104:10625-30. (Pubitemid 47185715)
20. Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 2010;16:665-70.
21. Palmer CD, Mutch BE, Workman S, McDaid JP, Horwood NJ, Foxwell BM. Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF-κB activity. Blood 2008;111:1781-88. (Pubitemid 351451482)
22. Semaan N, Alsaleh G, Gottenberg JE, Wachsmann D, Sibilia J. Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways. J Immunol 2008;180:3485-91.
23. Schomber T, Zumsteg A, Strittmatter K, Crnic I, Antoniadis H, Littlewood-Evans A, et al. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis. Mol Cancer Ther 2009;8: 55-63.
24. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009;21:154-65.
25. Pan S, An P, Zhang R, He X, Yin G, Min W. Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol Cell Biol 2002;22:7512-23.
26. Chau CH, Clavijo CA, Deng HT, Zhang Q, Kim KJ, Qiu Y, et al. Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems. Am J Physiol Cell Physiol 2005;289:C444-54. (Pubitemid 41008891)
27. Kaukonen J, Lahtinen I, Laine S, Alitalo K, Palotie A. BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias. Br J Haematol 1996;94:455-60. (Pubitemid 26284066)
28. Ekman N, Lymboussaki A, Västrik I, Sarvas K, Kaipainen A, Alitalo K. Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries. Circulation 1997;96: 1729-32. (Pubitemid 27400725)
29. Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, Silva CM. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 2008;22:1781-96.
30. Luo D, Luo Y, He Y, Zhang H, Zhang R, Li X, et al. Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am J Pathol 2006;169: 1886-98. (Pubitemid 351182017)
31. Al-Lamki RS, Sadler TJ, Wang J, Reid MJ, Warren AY, Movassagh M, et al. Tumor necrosis factor receptor expression and signaling in renal cell carcinoma. Am J Pathol 2010;177:943-54.
32. Cohen I, Maoz M, Turm H, Grisaru-Granovsky S, Maly B, Uziely B, et al. Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance. PLoS One 2010;5:e11135.
33. Chen R, Kim O, Li M, Xiong X, Guan JL, Kung HJ, et al. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat Cell Biol 2001;3: 439-44. (Pubitemid 32422078)
34. Abassi YA, Rehn M, Ekman N, Alitalo K, Vuori K. p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J Biol Chem 2003;278:35636-43. (Pubitemid 37102337)
35. Mathews LA, Hurt EM, Zhang X, Farrar WL. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer 2010;9:267.
36. Hur W, Velentza A, Kim S, Flatauer L, Jiang X, Valente D, et al. Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase. Bioorg Med Chem Lett 2008;18:5916-9.